| Global Pharmaceutical Market Forecast to 2012 | | | | § North America remains the largest pharmaceutical |
| The global pharmaceutical market is expected to earn | | | | market constituting 42.8% of the global sales in 2007. |
| over a trillion dollar in revenues by 2012 and according | | | | Growth in the region is however expected to slow |
| to "Global Pharmaceutical Market Forecast to | | | | down in near future owing to patent expiration of key |
| 2012”, our new research report, the market will | | | | drugs and increased prevalence of generics. |
| witness a number of changes impacting its course of | | | | § In Europe, growth in the top five markets is |
| growth. These include the shift of growth from the | | | | expected to remain sluggish in next five years. |
| developed markets to the emerging ones, increasing | | | | Emerging markets in Central and Eastern Europe is |
| focus on biotech-based drugs, fewer new drug | | | | however expected to drive growth in future. |
| approvals, and a strong growth in the prevalence of | | | | § A large untapped population and strong economic |
| generics. ( ) | | | | growth in major countries is expected to make |
| This report, an updated and far more exhaustive and | | | | Asia-Pacific the most lucrative pharmaceutical market |
| analytical version of our popular 2006 study, provides a | | | | in future. |
| comprehensive analysis of every major | | | | § Growth in the Latin American markets is expected |
| pharmaceutical market worldwide. Thirty-four major | | | | to be strong with Brazil and Mexico amongst the most |
| pharmaceutical markets from North America, Latin | | | | emerging pharmaceutical markets in the world. |
| America, Europe, Asia-Pacific and Africa have been | | | | § Dwindling drug pipelines and patent expiration of a |
| selected as the most important regions to be | | | | number of blockbuster drugs may challenge the |
| presented in this report. Factual insight, supplemented | | | | growth of global pharmaceutical market in future. |
| with statistical overview on the past, present and | | | | Key Players Discussed in the Report |
| future, together with statistics and analysis pertaining to | | | | This section provides the overview, key facts, |
| market size, growth, segmentation, government | | | | strengths and weaknesses, and financial information of |
| policies, healthcare indicators, key players, health | | | | prominent players in the global pharmaceutical market |
| coverage, new developments and future prospects | | | | like Pfizer Inc, Sanofi-Aventis, GlaxoSmithKline Plc and |
| has been provided for each market. | | | | AstraZeneca Plc. |
| "Global Pharmaceutical Market Forecast to 2012” | | | | Key Issues and Facts Analyzed in the Report |
| acts as a valuable tool for pharmaceutical | | | | § What are the emerging trends in the global |
| manufactures/investors/consultants who are studying | | | | pharmaceutical sector? |
| the global pharmaceutical market as it helps in | | | | § What are the future prospects of the |
| identifying and analyzing market opportunities that will | | | | pharmaceutical industry in various regions across the |
| suit their business needs and profiles. | | | | world? |
| Key Research Findings | | | | § What opportunities exist for the industry? |
| § Growing at a CAGR of around 8%, the global | | | | § What challenges are being faced by the industry? |
| pharmaceutical market is forecasted to reach US$ | | | | § Who are the key players in the global |
| 1043.4 Billion in 2012. | | | | pharmaceutical market? |